Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RNS® System Epilepsy Post-Approval Study

NCT: NCT02403843 · COMPLETED

NCT IDNCT02403843
StatusCOMPLETED
Start Date2015-06
Completion2026-01

Brief Summary

The purpose of the study is to follow patients with partial onset seizures prospectively over 5 years in the real-world environment to gather data on the long-term safety and effectiveness of the RNS System at qualified CECs by qualified neurologists, epileptologists, and neurosurgeons trained on the RNS System.

Frequently Asked Questions

What is RNS® System Epilepsy Post-Approval Study?

RNS® System Epilepsy Post-Approval Study is a clinical trial registered under NCT02403843. Current status: COMPLETED.

What is the status of NCT02403843?

The current status of NCT02403843 (RNS® System Epilepsy Post-Approval Study) is: COMPLETED.

When did RNS® System Epilepsy Post-Approval Study start?

RNS® System Epilepsy Post-Approval Study started on 2015-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.